secwatch.observer — SEC 8-K summary
======================================

Issuer:     CARGO Therapeutics, Inc. (—)
CIK:        0001966494
Form:       8-K
Filed at:   2025-08-19T23:59:59+00:00
Accession:  0001193125-25-183141
Event type: m_and_a
Sentiment:  neutral
Materiality: 1.00
Item codes: 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CARGO Therapeutics acquired by Concentra for $4.379/share plus CVR; delisting underway
--------------------------------------------------------------------------------

- Tender offer closed Aug 18 with 71.48% of shares tendered; merger completed Aug 19 under DGCL Section 251(h).
- Shareholders receive $4.379 cash per share plus one nontransferable CVR per share under CVR Agreement dated Aug 19, 2025.
- All stock options and RSUs accelerated; in-the-money options and RSUs cashed out with CVRs, out-of-money options cancelled for no consideration.
- Board resigned; Kevin Tang appointed sole director and CEO, Michael Hearne CFO, Ryan Cole COO, Stew Kroll CDO, Thomas Wei CBO.
- Shares to be delisted from Nasdaq and deregistered under Sections 12(b) and 12(g) of the Exchange Act.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1966494/000119312525183141/0001193125-25-183141-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1966494/000119312525183141/d58314d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-183141

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer